Análisis de las flexibilidades contenidas en el acuerdo ADPIC a la luz de las patentes farmacéuticas
Uloženo v:
| Autor: | |
|---|---|
| Médium: | artículo original |
| Stav: | Versión publicada |
| Datum vydání: | 2014 |
| Popis: | The inclusion of intellectual property matters within the WTO framework brought several consequences on developing countries. Patentability of phar maceutical products must be particulary empha - sized as to its potential impact on public health. Therefore, the flexibilities encompassed within the TRIPS Agreement should be seen as safeguards which allow protecting public interests, while complying with pharmaceutical patents regulations. The exami nation of technical issues contained in the treaty is essential for achieving a full understanding of the scope of the obligations acquired by the State parties. |
| Země: | Portal de Revistas UCR |
| Instituce: | Universidad de Costa Rica |
| Repositorio: | Portal de Revistas UCR |
| Jazyk: | Español |
| OAI Identifier: | oai:archivo.portal.ucr.ac.cr:article/13249 |
| On-line přístup: | https://archivo.revistas.ucr.ac.cr/index.php/juridicas/article/view/13249 |
| Klíčové slovo: | TRIPS Agreement parallel imports Bolar exemption test data mandatory licensing public health Acuerdo ADPIC importaciones paralelas cláu- sula Bolar datos de prueba licencias obligatorias salud pública |